09 marzo 2021 06:48
Fonte: Adnkronos
#chimica-e-farmacia
HANG ZHOU, China, March 9, 2021 /PRNewswire/ On Feb. 26th, 2021, Hongkong Winhealth Pharma Group Co., Ltd (hereinafter referred to as Winhealth Pharma ) signed a strategic cooperation agreement with Merz Pharmaceuticals GmbH (hereinafter referred to as Merz ). The strategic cooperation between the two parties marks the obtainment of Winhealth Pharma for the exclusive commercial rights of Hepa-Merz® (L-ornithine L-aspartate, an important product under Merz product portfolio) in China.
About L-ornithine L-aspartate and hepatic encephalopathy (HE)
L-ornithine L-aspartate (LOLA) is a stable salt of two amino acids that stimulates ammonia detoxification by increasing urea synthesis in the liver and muscle, thereby reducing the blood ammonia content in the brain which causes hepatic encephalopathy in cirrhotic patients.